Dr. Talha Badar of Mayo Clinic discusses the results of Quantum First, a randomized, phase III trial evaluating the efficacy of Quizartinib in treating Acute Myeloid Leukemia (AML) with FLT3-ITD mutation.
Dr. Talha Badar of Mayo Clinic discusses the results of Quantum First, a randomized, phase III trial evaluating the efficacy of Quizartinib in treating Acute Myeloid Leukemia (AML) with FLT3-ITD mutation.
More